Medical Imaging

Approvals News

New Diagnostic Drug Flyrcado Enhances Coronary Artery Disease Diagnosis

Advancing MS Clinical Trials: Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes

September 17, 2024

Streamlining Clinical Trial Imaging Workflows: From Collection to Completion

September 13, 2024

Next-Gen Image Analysis in Regulated Environments: Automation Meets Compliance

July 10, 2024

How Can AI-Assisted Image Analysis Boost Productivity in Preclinical Research, Including GLP?

June 17, 2024

Using Prognostic AI Models in Pathology: Case Colorectal Cancer

June 13, 2024
Approvals News

Avicenna.AI Gets FDA Clearance for AI-Powered CT Scan Tools for Pulmonary Embolism and Stroke Assessment

The Incretin Impact: A New Era in Metabolic Disease and Obesity Drug Development

May 02, 2024

Enhancing Prostate Cancer Screening: AI, Imaging and Clinical Innovations

March 22, 2024

Underneath the Lost Kilos: Weight Loss in Metabolic Disease

October 25, 2023

Advances in oncological imaging: Tumour growth rate modelling and radiomics

October 12, 2023

Achieving Success in Neuroscience Clinical Trials: An Integrated CRO Approach

September 14, 2023
Approvals News

Ultravist (Iopromide) Paves New Path in Breast Cancer Detection
Approvals News

Posluma Is a Novel PET Imaging Agent for Prostate Cancer Detection
Blogs

Interview with Polarean Imaging CTO Dr. Bastiaan Driehuys on the FDA Approval of Lung Imaging Drug Device Combo Xenoview – Xtalks Life Science Podcast Ep. 97
Approvals News

Orthopedic Imaging System from Adaptix Gets FDA 510(k) Clearance